The Norwegian Radium Hospital, The Research Building
In a recent article in Nature Communications, published online on the 28th of June, 2019, PhD student Marte Sneeggen and her coworkers at the Institute for Cancer Research and the Center for Cancer Cell Reprogramming (CanCell) identify a new mechanism how the tumor suppressor WDFY2 prevents metastasis by controlling recycling of the matrix metalloproteinase MT1-MMP
Harald Stenmark and his colleagues have received a joint grant with French researchers from the group of Philippe Chavrier at the Institut Curie in Paris. The funds were donated by Trond S. Paulsen and allocated by 'Radiumhospitalets Legates' to combat cancer cell invasiveness through the project Invacell.
On May 8th CanCell invited four representative from Cancer Patient Interest groups to present their perspective on cancer and cancer research and to give feedback on the applications proposed by the Centre's scientists.
CanCell co-director and professor Anne Simonsen received the prestigious King Olav V's Prize for Cancer Research at a ceremony at the University of Oslo today.
In a recent paper in Nature Cell Biology, Alf Håkon Lystad and Laura Rodriguez de la Balina in Anne Simonsen's group unveil fundamental mechanisms of autophagy related processes.
CanCell had its first visit by the Scientific Advisory Board (SAB) on March 11th- 12th. The SAB consisting of Johanna Ivaska, Marja Jäättelä, Pier Paolo Di Fiore, Stephan Beck and Michael Boutros was introduced to the Centre's activities and strategies.
CanCell associate members Åslaug Helland and Arnoldo Frigessi were featured in both Apollon (UiO) and Norwegian Broadcasting (NRK) for their work on developing artificial intelligence to improve cancer therapy.
The Institute of Basic Medical Sciences gives a warm welcome to Ragnhild Eskeland's research group with a interview and focus on epigenetics.